A selective USP1-UAF1 inhibitor links deubiquitination to DNA damage responses.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Nature Chemical Biology

• Publication date

  2014-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/nchembio.1455PMID 24531842PMCID PMC4144829
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FANC Pathway Promotes UV-Induced Stalled Replication Forks Recovery by Acting Both Upstream and Downstream Polη and Rev1

  2013cited by this paper
• Translesion Synthesis of 8,5′-Cyclopurine-2′-deoxynucleosides by DNA Polymerases η, ι, and ζ*

  2013cited by this paper
• Mitoxantrone Targets Human Ubiquitin-Specific Peptidase 11 (USP11) and Is a Potent Inhibitor of Pancreatic Cancer Cell Survival

  2013cited by this paper
• FANCD2 activates transcription of TAp63 and suppresses tumorigenesis.

  2013cited by this paper
• Serine phosphorylation is critical for the activation of ubiquitin-specific protease 1 and its interaction with WD40-repeat protein UAF1.

  2012cited by this paper
• The Fanconi anaemia pathway orchestrates incisions at sites of crosslinked DNA

  2012cited by this paper
• Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway.

  2012cited by this paper
• Intrinsic Flexibility of Ubiquitin on Proliferating Cell Nuclear Antigen (PCNA) in Translesion Synthesis

  2012cited by this paper
• A Quantitative Assay for Assessing the Effects of DNA Lesions on Transcription

  2012cited by this paper
• Deubiquitinases in cancer: new functions and therapeutic options

  2012cited by this paper
• A UV-independent pathway to melanoma carcinogenesis in the redhair-fairskin background

  2012cited by this paper
• USP1 deubiquitinates ID proteins to preserve a mesenchymal stem cell program in osteosarcoma.

  2011cited by this paper
• Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes.

  2011cited by this paper
• Predisposition to Cancer Caused by Genetic and Functional Defects of Mammalian Atad5

  2011cited by this paper
• The Roles of DNA Polymerases κ and ι in the Error-free Bypass of N2-Carboxyalkyl-2′-deoxyguanosine Lesions in Mammalian Cells*

  2011cited by this paper
• USP1 deubiquitinase maintains phosphorylated CHK1 by limiting its DDB1-dependent degradation

  2011cited by this paper
• Ubiquitination of PCNA and Its Essential Role in Eukaryotic Translesion Synthesis

  2011cited by this paper
• Location of inhibitor binding sites in the human inducible prostaglandin E synthase, MPGES1.

  2011cited by this paper
• Selective and cell-active inhibitors of the USP1/ UAF1 deubiquitinase complex reverse cisplatin resistance in non-small cell lung cancer cells.

  2011cited by this paper
• Regulation of Rev1 by the Fanconi Anemia Core Complex

  2011cited by this paper
• Drug combination studies and their synergy quantification using the Chou-Talalay method.

  2010cited by this paper
• Cisplatin resistance: preclinical findings and clinical implications.

  2010cited by this paper
• Human ELG1 Regulates the Level of Ubiquitinated Proliferating Cell Nuclear Antigen (PCNA) through Its Interactions with PCNA and USP1*

  2010cited by this paper
• O6-Methylguanine induces altered proteins at the level of transcription in human cells

  2010cited by this paper
• Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling

  2010cited by this paper
• Distinct pose of discodermolide in taxol binding pocket drives a complementary mode of microtubule stabilization.

  2009cited by this paper
• Nonproteolytic functions of ubiquitin in cell signaling.

  2009cited by this paper
• Defining the human deubiquitinating enzyme interaction landscape.

  2009cited by this paper
• The Fanconi anemia pathway: insights from somatic cell genetics using DT40 cell line.

  2009cited by this paper
• Inactivation of murine Usp1 results in genomic instability and a Fanconi anemia phenotype.

  2009cited by this paper
• DNA damage tolerance: when it's OK to make mistakes.

  2009cited by this paper
• Regulation of polymerase exchange between Polη and Polδ by monoubiquitination of PCNA and the movement of DNA polymerase holoenzyme

  2008cited by this paper
• Homologous recombination in DNA repair and DNA damage tolerance

  2008cited by this paper
• Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins

  2007cited by this paper
• Nucleotide Excision Repair Eliminates Unique DNA-Protein Cross-links from Mammalian Cells*

  2007cited by this paper
• The resurgence of platinum-based cancer chemotherapy

  2007cited by this paper
• Deubiquitination of FANCD2 Is Required for DNA Crosslink Repair

  2007cited by this paper
• Inaugural Article: Insights into the mechanism of microtubule stabilization by Taxol

  2006cited by this paper
• Regulation of monoubiquitinated PCNA by DUB autocleavage

  2006cited by this paper
• Assays for determining lesion bypass efficiency and mutagenicity of site-specific DNA lesions in vivo.

  2006cited by this paper
• Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.

  2006cited by this paper
• Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries.

  2006cited by this paper
• A genomic and functional inventory of deubiquitinating enzymes.

  2005cited by this paper
• A role for polymerase eta in the cellular tolerance to cisplatin-induced damage.

  2005cited by this paper
• Mutagenesis, genotoxicity, and repair of 1-methyladenine, 3-alkylcytosines, 1-methylguanine, and 3-methylthymine in alkB Escherichia coli.

  2004cited by this paper
• Mechanism and function of deubiquitinating enzymes.

  2004cited by this paper
• Dopamine and mania: Behavioral and biochemical effects of the dopamine receptor blocker pimozide

  2004cited by this paper
• The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair.

  2004cited by this paper
• Opposing Effects of Ubiquitin Conjugation and SUMO Modification of PCNA on Replicational Bypass of DNA Lesions in Saccharomyces cerevisiae

  2004cited by this paper
• Control of spontaneous and damage-induced mutagenesis by SUMO and ubiquitin conjugation

  2003cited by this paper
• Multiple roles of Rev3, the catalytic subunit of polζ in maintaining genome stability in vertebrates

  2003cited by this paper
• A novel technique with enhanced detection and quantitation of HPV-16 E1- and E2-mediated DNA replication.

  2003cited by this paper
• Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family.

  2002cited by this paper
• Molecular aspects of resistance to antitumor platinum drugs.

  2002cited by this paper
• RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO

  2002cited by this paper
• Identification of a subtype selective human PPARalpha agonist through parallel-array synthesis.

  2001cited by this paper
• Efficient bypass of a thymine-thymine dimer by yeast DNA polymerase, Poleta.

  1999cited by this paper
• Clinical development of platinum complexes in cancer therapy: an historical perspective and an update.

  1998cited by this paper
• The efficiency and timing of plasmid DNA replication in Xenopus eggs: correlations to the extent of prior chromatin assembly.

  1992cited by this paper

• Ubiquitin System-Driven Proteostasis in DNA Damage Response

  2026cites this paper
• Synergistic Cellular Toxicity from Inhibition of Poly(ADP-ribose) Glycohydrolase (PARG) and Ubiquitin-Specific Protease 1 (USP1).

  2026cites this paper
• The Potential Role of Deubiquitinating Enzymes (DUBs) in Male Fertility.

  2026cites this paper
• From Covalent Traps to Fluorescent Beacons: The Expanding Arsenal of Chemical Probes for Studying Ubiquitin and Ubiquitin-Like Proteins.

  2026cites this paper
• RPA exhaustion activates SLFN11 to eliminate cells with heightened replication stress

  2026cites this paper
• CRISPR/Cas9-based genome-wide screen reveals a synergistic effect of Irinotecan and USP1 inhibitor in colorectal cancer.

  2026cites this paper
• Unraveling the mechanisms of ubiquitin-specific proteases in hepatocellular carcinoma: A focus on inhibitors.

  2025cites this paper
• Unraveling the role of deubiquitinating enzymes on cisplatin resistance in several cancers.

  2025cites this paper
• Harnessing the Deubiquitinase USP1 for Targeted Protein Stabilization.

  2025cites this paper
• Expression Patterns of Deubiquitinating Enzymes in Paclitaxel‐Treated Lung Cancer Cells

  2025cites this paper
• USP1 inhibition: A journey from target discovery to clinical translation.

  2025cites this paper
• Ubiquitin-specific proteases as emerging molecular drivers and therapeutic targets in hepatobiliary cancers

  2025cites this paper
• The FANCD2-FANCI heterodimer coordinates chromatin openness and cell cycle progression throughout DNA double-strand break repair

  2025cites this paper
• Targeting DNA repair mechanisms in cancer therapy: the role of small molecule DNA repair inhibitors

  2025cites this paper
• Discovery and Optimization of Novel Tricyclic Ubiquitin-Specific Protease 1 Inhibitors for the Treatment of BRCA-Mutated Breast Cancer.

  2025cites this paper
• AKT and DUBs: a bidirectional relationship

  2025cites this paper
• Mechanistic insights into the monotherapy and combination potential of FEN1 inhibition in cancer therapy

  2025cites this paper
• OTU deubiquitinases in cancer pathogenesis and precision therapy.

  2025cites this paper
• Targeting Cellular DNA Damage Response in Cancer and Bacterial Infections: Current Progress, Challenges, and Opportunities

  2025cites this paper
• Discovery of TNG-6132, a potent, selective, and orally bioavailable USP1 inhibitor.

  2025cites this paper
• PI5P4K inhibitors: promising opportunities and challenges

  2025cites this paper
• Exploiting synthetic lethality in PDAC with antibody drug conjugates and ATR inhibition.

  2025cites this paper
• Computational analysis of energetic features and intermolecular interactions in protein-inhibitor USP7 complexes.

  2025cites this paper
• The USP1-WDR48 deubiquitinase complex functions as a molecular switch regulating tumor-associated macrophage activation and anti-tumor response

  2025cites this paper
• USP1 in regulation of DNA repair pathways.

  2025cites this paper
• Molecular glues that inhibit deubiquitylase activity and inflammatory signaling

  2025cites this paper
• N6-methyladenosine (m6A)-forming enzyme METTL3 controls UAF1 stability to promote inflammation in a model of colitis by stimulating NLRP3

  2025cites this paper
• Discovery and Optimization of a Series of Novel Morpholine-Containing USP1 Inhibitors.

  2025cites this paper
• SLFN11 counteracts the RFWD3-PRIMPOL DNA damage tolerance axis to restrain gapped DNA synthesis in response to replication stress

  2025cites this paper
• The other side of the coin: protein deubiquitination by Ubiquitin-Specific Protease 1 in cancer progression and therapy.

  2025cites this paper
• New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives

  2024influential citation
• USP1-dependent nucleolytic expansion of PRIMPOL-generated nascent DNA strand discontinuities during replication stress

  2024cites this paper
• Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options

  2024cites this paper
• The Role of Deubiquitinating Enzymes in Primary Bone Cancer

  2024cites this paper
• The Role of Ubiquitination in Osteosarcoma Development and Therapies

  2024cites this paper
• Rolapitant treats lung cancer by targeting deubiquitinase OTUD3

  2024cites this paper
• Optimizing the Affinity Selection Mass Spectrometry Workflow for Efficient Identification and Ranking of Potent USP1 Inhibitors.

  2024cites this paper
• Roles of USP1 in Ewing sarcoma

  2024cites this paper
• The P53–P21–RB1 pathway promotes BRD4 degradation in liver cancer through USP1

  2024cites this paper
• A closer look at the role of deubiquitinating enzymes in the Hypoxia Inducible Factor pathway

  2024cites this paper
• Advances in Research on Ubiquitin Modification and Deubiquitinating Enzymes in Cancer Therapy

  2024cites this paper
• Polyubiquitinated PCNA triggers SLX4-mediated break-induced replication in alternative lengthening of telomeres (ALT) cancer cells

  2024cites this paper
• The deubiquitinase cofactor UAF1 interacts with USP1 and plays an essential role in spermiogenesis

  2024cites this paper
• Structural and Biochemical Insights into the Mechanism of Action of the Clinical USP1 Inhibitor, KSQ-4279

  2024cites this paper
• Molecular glues that inhibit deubiquitylase activity and inflammatory signalling

  2024cites this paper
• The role of ubiquitination in health and disease

  2024cites this paper
• Disulfide-containing polymer delivery of C527 and a Platinum(IV) prodrug selectively inhibited protein ubiquitination and tumor growth on cisplatin resistant and patient-derived liver cancer models

  2023cites this paper
• The Deubiquitinating Enzyme USP1 is Auto-Ubiquitinated and Destabilized by ML323 in Colorectal Cancer Cells

  2023cites this paper
• Discovery of an OTUD3 inhibitor for the treatment of non-small cell lung cancer

  2023cites this paper
• Contribution of microRNA-30d to the prevention of the thyroid cancer occurrence and progression: mechanism and implications

  2023cites this paper
• Inhibitors of the Ubiquitin-Mediated Signaling Pathway Exhibit Broad-Spectrum Antiviral Activities against New World Alphaviruses

  2023cites this paper
• Comprehensive Interrogation of Synthetic Relationships in the Human DNA Damage Response

  2023cites this paper
• Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy

  2023cites this paper
• RNA methylation, homologous recombination repair and therapeutic resistance.

  2023cites this paper
• Deubiquitinase USP1 enhances CCAAT/enhancer-binding protein beta (C/EBPβ) stability and accelerates adipogenesis and lipid accumulation

  2023cites this paper
• The UAF1-USP1 Deubiquitinase Complex Stabilizes cGAS and Facilitates Antiviral Responses.

  2023cites this paper
• Polyubiquitinated PCNA promotes alternative lengthening of telomeres by inducing break-induced replication

  2023cites this paper
• Pharmacological inhibition of BAP1 recruits HERC2 to competitively dissociate BRCA1–BARD1, suppresses DNA repair and sensitizes CRC to radiotherapy

  2023cites this paper
• Spotlights on ubiquitin-specific protease 12 (USP12) in diseases: from multifaceted roles to pathophysiological mechanisms

  2023cites this paper
• Ubiquitin-specific peptidase 1: assessing its role in cancer therapy

  2023cites this paper
• Cellular assays for dynamic quantification of deubiquitinase activity and inhibition.

  2023cites this paper
• PCNA Ser46-Leu47 residues are crucial in preserving genomic integrity

  2023cites this paper
• Discovery and Characterization of BAY-805, a Potent and Selective Inhibitor of Ubiquitin-Specific Protease USP21

  2023cites this paper
• Deubiquitinase USP1 regulates sarbecovirus ORF6 protein function

  2023cites this paper
• Deubiquitylating Enzymes in Cancer and Immunity

  2023cites this paper
• Implications of ubiquitination and the maintenance of replication fork stability in cancer therapy

  2023cites this paper
• The promotive role of USP1 inhibition in coordinating osteogenic differentiation and fracture healing during nonunion

  2023cites this paper
• USP1 Expression Driven by EWS::FLI1 Transcription Factor Stabilizes Survivin and Mitigates Replication Stress in Ewing Sarcoma

  2023cites this paper
• The Emerging Role of Deubiquitinases in Radiosensitivity.

  2023cites this paper
• Structural and biochemical basis of interdependent FANCI‐FANCD2 ubiquitination

  2022cites this paper
• Ubiquitin-specific protease 35 (USP35) mediates cisplatin-induced apoptosis by stabilizing BIRC3 in non-small cell lung cancer

  2022cites this paper
• HPV Enhances HNSCC Chemosensitization by Inhibiting SERPINB3 Expression to Disrupt the Fanconi Anemia Pathway

  2022cites this paper
• The activated ATM/AMPK/mTOR axis promotes autophagy in response to oxidative stress-mediated DNA damage co-induced by molybdenum and cadmium in duck testes.

  2022cites this paper
• Deubiquitinase USP1 influences the dedifferentiation of mouse pancreatic β-cells

  2022influential citation
• Targeting Homologous Recombination Deficiency in Ovarian Cancer with PARP Inhibitors: Synthetic Lethal Strategies That Impact Overall Survival

  2022cites this paper
• The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy

  2022cites this paper
• Ubiquitinated PCNA Drives USP1 Synthetic Lethality in Cancer

  2022influential citation
• DNA Damage Tolerance Pathways in Human Cells: A Potential Therapeutic Target

  2022cites this paper
• Inhibition of USP1 activates ER stress through Ubi-protein aggregation to induce autophagy and apoptosis in HCC

  2022cites this paper
• ML323 suppresses the progression of ovarian cancer via regulating USP1-mediated cell cycle

  2022cites this paper
• Potential New Therapeutic Approaches for Cisplatin-Resistant Testicular Germ Cell Tumors.

  2022cites this paper
• Knockdown of UAF1 alleviates sevoflurane-induced cognitive impairment and neurotoxicity in rats by inhibiting pro-inflammatory signaling and oxidative stress.

  2022cites this paper
• Immunoexpression of tumor suppressor protein p53 and deubiquitinating enzymes in oral squamous cell carcinoma

  2022cites this paper
• Deubiquitinating enzymes: promising targets for drug resistance.

  2022cites this paper
• Identification of a chemical probe for lipid kinase phosphatidylinositol-5-phosphate 4-kinase gamma (PI5P4Kγ)

  2022cites this paper
• Cryo-EM reveals a mechanism of USP1 inhibition through a cryptic binding site

  2022cites this paper
• The emerging role of ubiquitin-specific protease 20 in tumorigenesis and cancer therapeutics

  2022cites this paper
• Ubiquitin-specific protease 1 inhibition sensitizes hepatocellular carcinoma cells to doxorubicin by ubiquitinated proliferating cell nuclear antigen–mediated attenuation of stemness

  2022cites this paper
• USP1-trapping lesions as a source of DNA replication stress and genomic instability

  2022cites this paper
• On the Study of Deubiquitinases: Using the Right Tools for the Job

  2022cites this paper
• Inhibition of USP1 enhances anticancer drugs-induced cancer cell death through downregulation of survivin and miR-216a-5p-mediated upregulation of DR5

  2022influential citation
• USP1-trapping lesions as a source of DNA replication stress and genomic instability

  2022cites this paper
• USP1 inhibition suppresses the progression of osteosarcoma via destabilizing TAZ

  2022cites this paper
• The emerging role of deubiquitylating enzymes as therapeutic targets in cancer metabolism

  2022cites this paper
• Recent advances in the pharmacological targeting of ubiquitin-regulating enzymes in cancer.

  2022cites this paper
• ML323, a USP1 inhibitor triggers cell cycle arrest, apoptosis and autophagy in esophageal squamous cell carcinoma cells

  2022influential citation
• Structure-Activity Relationship of USP5 Inhibitors.

  2021cites this paper
• The Ubiquitin System: An Emerging Therapeutic Target for Lung Cancer

  2021cites this paper
• Ubiquitin-specific proteases as therapeutic targets in paediatric primary bone tumours?

  2021cites this paper
• Redox regulation of DUBs and its therapeutic implications in cancer

  2021cites this paper